Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Share-based Compensation (2024 - 2025)

Profound Medical has reported Share-based Compensation over the past 2 years, most recently at $1.4 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $1.4 million for Q4 2025, up 212.44% from a year ago — trailing twelve months through Dec 2025 was $5.5 million (up 112.71% YoY), and the annual figure for FY2025 was $5.5 million, up 112.71%.
  • Share-based Compensation for Q4 2025 was $1.4 million at Profound Medical, down from $1.7 million in the prior quarter.
  • Over the last five years, Share-based Compensation for PROF hit a ceiling of $1.7 million in Q3 2025 and a floor of $442000.0 in Q4 2024.